Munich - Delayed Quote EUR

Tvardi Therapeutics Inc. R (69C.MU)

16.88
+0.74
+(4.56%)
At close: April 24 at 8:23:53 AM GMT+2
Loading Chart for 69C.MU
  • Previous Close 16.14
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 17.00
  • Volume 0
  • Avg. Volume 8
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 69C.MU

View More

Performance Overview: 69C.MU

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

69C.MU
0.71%
S&P 500 (^GSPC)
6.75%

1-Year Return

69C.MU
0.71%
S&P 500 (^GSPC)
8.15%

3-Year Return

69C.MU
0.71%
S&P 500 (^GSPC)
28.40%

5-Year Return

69C.MU
0.71%
S&P 500 (^GSPC)
93.35%

Compare To: 69C.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 69C.MU

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    152.32M

  • Enterprise Value

    144.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 69C.MU

View More

Company Insights: 69C.MU

Research Reports: 69C.MU

View More